Expression of Multiple Taenia Solium Immunogens in Plant Cells Through a Ribosomal Skip Mechanism

Molecular Biotechnology

Volumn 57, Issue 7, 2015, Pages 635-643

  Monreal Escalante, Elizabeth ^a   Bañuelos Hernández, Bernardo ^a   Hernández, Marisela ^b   Fragoso, Gladis ^b   Garate, Teresa ^c   Sciutto, Edda ^b   Rosales Mendoza, Sergio ^a  

^a UNIVERSIDAD AUTÓNOMA DE SAN LUIS POTOSÍ   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Low cost expression platform; Multicomponent vaccine; Plant derived immunogen

Indexed keywords

ANTIBODIES; ANTIGENS; CEREBROSPINAL FLUID; COSTS; DIAGNOSIS; EPITOPES; LIFE CYCLE; PROTEINS; RECOMBINANT PROTEINS; VIRUSES;

CEREBRAL SPINAL FLUIDS; FOOT-AND-MOUTH DISEASE VIRUS; LOW COSTS; MULTICOMPONENTS; NOVEL STRATEGIES; PLANT-DERIVED IMMUNOGEN; PROTEIN ACCUMULATION; TRANSGENIC TOBACCO;

VACCINES;

PARASITE ANTIGEN; PLANT DNA; PLANT RNA; RECOMBINANT PROTEIN; ANTIGEN; EPITOPE; VACCINE;

ANTIGEN EXPRESSION; ARTICLE; CEREBROSPINAL FLUID; CONTROLLED STUDY; FOOT AND MOUTH DISEASE VIRUS; NEUROCYSTICERCOSIS; NONHUMAN; PLANT CELL; PLANT LEAF; PROTEIN CLEAVAGE; RIBOSOME; TAENIA SOLIUM; TOBACCO; ANIMAL; BIOSYNTHESIS; CYSTICERCOSIS; GENETICS; HUMAN; IMMUNIZATION; IMMUNOLOGY; MOUSE; PARASITOLOGY; PATHOGENICITY; PIG;

FOOT-AND-MOUTH DISEASE VIRUS; MUS; NICOTIANA TABACUM; SUS; TAENIA SOLIUM;

ANIMALS; ANTIGENS; CYSTICERCOSIS; EPITOPES; FOOT-AND-MOUTH DISEASE VIRUS; HUMANS; IMMUNIZATION; MICE; PLANT CELLS; RECOMBINANT PROTEINS; RIBOSOMES; SWINE; TAENIA SOLIUM; VACCINES;

EID: 84930869950     PISSN: 10736085     EISSN: 15590305     Source Type: Journal    
DOI: 10.1007/s12033-015-9853-6     Document Type: Article

References (51)

1. Sciutto, E., Fragoso, G., Fleury, A., Laclette, J. P., Sotelo, J., Aluja, A., et al. (2000). Taenia solium disease in humans and pigs: An ancient parasitosis disease rooted in developing countries and emerging as a major health problem of global dimensions. Microbes and Infection,2, 1875–1890.
2. De Aluja, A. S. (2008). Cysticercosis in the pig. Current Topics in Medicinal Chemistry,8, 368–374.
3. Sotelo, J. (2011). Clinical manifestations, diagnosis, and treatment of neurocysticercosis. Current Neurology and Neuroscience Reports,11, 529–535.
4. Molinari, J., Rodriguez, D., Tato, P., Soto, R., & Arechavaleta, Solano S. (1997). Field trial for reducing porcine Taenia solium cysticercosis in Mexico by systematic vaccination of pigs. Veterinary Parasitology,69, 55–63.
5. Flisser, A., Gauci, C. G., Zoli, A., Martinez-Ocana, J., Garza-Rodriguez, A., Dominguez-Alpizar, J. L., et al. (2004). Induction of protection against porcine cysticercosis by vaccination with recombinant oncosphere antigens. Infection and Immunity,72, 5292–5297.
6. Huerta, M., de Aluja, A. S., Fragoso, G., Toledo, A., Villalobos, N., & Hernández, M. (2001). Synthetic peptide vaccine against Taenia solium pig cysticercosis: successful vaccination in a controlled field trial in rural Mexico. Vaccine,20, 262–266.
7. Morales, J., Martínez, J. J., Manoutcharian, K., Hernández, M., & Fleury, Gevorkian G. (2008). Inexpensive anti-cysticercosis vaccine: S3Pvac expressed in heat inactivated M13 filamentous phage proves effective against naturally acquired Taenia solium porcine cysticercosis. Vaccine,26, 2899–2905.
8. Assana, E., Kyngdon, C. T., Gauci, C. G., Geerts, S., Dorny, P., & De Deken, R. (2010). Elimination of Taenia solium transmission to pigs in a field trial of the TSOL18 vaccine in Cameroon. International Journal for Parasitology,40, 515–519.
9. Rassy, D., Bobes, R. J., Rosas, G., Anaya, V. H., Brehm, K., & Hernandez, B. (2010). Characterization of S3Pvac anti-cysticercosis vaccine components: implications for the development of an anti-cestodiasis vaccine. PLoS One,5, 11287–11291.
10. Morales, J., de Aluja, A. S., Martínez, J. J., Hernández, M., Rosas, G., & Villalobos, N. (2011). Recombinant S3Pvac-phage anti-cysticercosis vaccine: simultaneous protection against cysticercosis and hydatid disease in rural pigs. Veterinary Parasitology,176, 53–58.
11. Olguín, S. (2010). Programa de control de la teniasis-cisticercosis. Gaceta Biomédica,15, 8–9.
12. Benitez, L., Garate, T., Harrison, L. J., Kirkham, P., Brookes, S. M., & Parkhouse, R. M. (1996). Cloning and sequencing of the gene encoding the principal 18-kDa secreted antigen of activated oncospheres of Taenia saginata. Molecular and Biochemical Parasitology,78, 265–268.
13. Harrison, G. B., Heath, D. D., Dempster, R. P., Gauci, C., Newton, S. E., Cameron, W. G., et al. (1996). Identification and cDNA cloning of two novel low molecular weight host-protective antigens from Taenia ovis oncospheres. International Journal for Parasitology,26, 195–204.
14. Gauci, C. G., Flisser, A., & Lightowlers, M. W. (1998). Taenia solium oncosphere protein homologous to host-protective Taenia ovis and Taenia saginata 18 kDa antigens. International Journal for Parasitology,28, 757–760.
15. Parkhouse, R. M., Bonay, P., González, L. M., Ferrer, E., Gárate, T., Aguilar, C. M., et al. (2008). TSOL18/HP6-Tsol, an immunogenic Taenia solium oncospheral adhesion protein and potential protective antigen. Parasitology Research,102, 921–926.
16. Hernández, M., Rosas, G., Cervantes, J., Fragoso, G., Rosales-Mendoza, S., & Sciutto, E. (2014). Transgenic plants: a 5-year update on oral antipathogen vaccine development. Expert Rev Vaccines.,13, 1523–1536.
17. Yusibov, V., Streatfield, S. J., & Kushnir, N. (2011). Clinical development of plant-produced recombinant pharmaceuticals: Vaccines, antibodies, and beyond. Human Vaccine,7, 313–321.
18. Mihaliak, C.A., Webb, S., Miller, T., Fanton, M., Kirk, D., Cardineau, G. (2005). Development of plant cell produced vaccines for animal health applications. In Proceedings of the 108th annual meeting of the United States Animal Health Association. (pp. 158–163) Greensboro, NC.
19. Aviezer, D., Brill-Almon, E., Shaaltiel, Y., Hashmueli, S., Bartfeld, D., Mizrachi, S., et al. (2009). A plant-derived recombinant human glucocerebrosidase enzyme a preclinical and phase I investigation. PLoS One,4, 4792–4797.
20. Hernández, M., Cabrera-Ponce, J. L., Fragoso, G., López-Casillas, F., & Guevara-García, A. (2007). A new highly effective anti-cysticercosis vaccine expressed in transgenic papaya. Vaccine,25, 4252–4260.
21. Betancourt, M. A., De Aluja, A. S., Sciutto, E., Hernández, M., Bobes, R. J., Rosas, G., et al. (2012). Effective protection induced by three different versions of the porcine S3Pvac anticysticercosis vaccine against rabbit experimental Taenia pisiformis cysticercosis. Vaccine,30, 2760–2767.
22. Rybicki, E. P. (2014). Plant-based vaccines against viruses. Virol J.,11, 1–20.
23. Rosales-Mendoza, S., Govea-Alonso, D. O., Monreal-Escalante, E., Fragoso, G., & Sciutto, E. (2012). Developing plant-based vaccines against neglected tropical diseases: Where are we? Vaccine,31, 40–48.
24. Luke G. (2012). Translating 2A research into practice, innovations in biotechnology, Dr. Eddy C. Agbo (Ed.) Biochemistry, Genetics and Molecular Biology, 8, 168–182.
25. Minskaia, E., Nicholson, J., & Ryan, M. D. (2013). Optimisation of the foot-and-mouth disease virus 2A co-expression system for biomedical applications. BMC Biotechnology,22, 13–67.
26. Ryan, M. D., Donnelly, M. L. L., Lewis, A., Mehrotra, A. P., Wilkie, J., & Gani, D. (1999). A model for Nonstoichiometric, Co-translational Protein Scission in Eukaryotic Ribosomes. Bioorganic Chemistry,27, 55–79.
27. Atkins, J. F., Wills, N. M., Loughran, G., Wu, C.-Y., Parsawar, K., Ryan, M. D., et al. (2007). A case for “StopGo”: Reprogramming translation to augment codon meaning of GGN by promoting unconventional termination (Stop) after addition of glycine and then allowing continued translation (Go). RNA,13, 803–810.
28. Doronina, V. A., de Felipe, P., Wu, C., Sharma, P., Sachs, M. S., Ryan, M. D., & Brown, J. D. (2008). Dissection of a co-translational nascent chain separation event. Biochemical Society Transaction,36, 712–716.
29. Ryan, M. D., & Drew, J. (1994). Foot-and-mouth disease virus 2A oligopeptide mediated cleavage of an artificial polyprotein. The EMBO Journal,13, 928–933.
30. Ryan, M. D., King, A. M. Q., & Thomas, G. P. (1991). Cleavage of foot-and-mouth disease virus polyprotein is mediated by residues located within a 19 amino acid sequence. Journal of General Virology,72, 2727–2732.
31. Donnelly, M. L. L., Luke, G. A., Mehrotra, A., Li, X., Hughes, L. E., Gani, D., & Ryan, M. D. (2001). Analysis of the aphthovirus 2A/2B polyprotein “cleavage” mechanism indicates not a proteolytic reaction, but a novel translational effect: a putative ribosomal “skip”. Journal General Virology,82, 1013–1025.
32. Doronina, V. A., Wu, C., de Felipe, P., Sachs, M. S., Ryan, M. D., & Brown, J. D. (2008). Site specific release of nascent chains from ribosomes at a sense codon. Molecular and Cellular Biology,28, 4227–4239.
33. Ryan, M. D., Luke, G. A., Hughes, L. E., Cowton, V. M., Ten-Dam, E., Xuejun, L., et al. (2002). The aphtho- and cardiovirus “Primary” 2A/2B polyprotein “Cleavage”. In B. L. Semler & E. Wimmer (Eds.), Molecular biology of picornaviruses (pp. 61–70). Washington, DC: ASM Press. ISBN 1-55581-210-4.
34. Martĩnez-Salas, E., & Ryan, M. D. (2010). Translation and protein processing. In E. Ehrenfeld, E. Domingo, & R. P. Roos (Eds.), The picornaviruses (pp. 141–161). Washington, DC: ASM Press.
35. Halpin, C., Cooke, S. E., Barakate, A., Amrani, A. E., & Ryan, M. D. (1999). Self-processing 2A-polyproteins—a system for co-ordinate expression of multiple protein in transgenic plants. The Plant Journal,17, 453–459.
36. Halpin, C., Askari, B. M., Abbot, J. C., & Ryan, M. D. (2001). Enabling technologies for manipulating multiple genes on complex pathways. Plant Molecular Biology,47, 295–331.
37. Manoutcharian, K., Rosas, G., Hernandez, M., Fragoso, G., Aluja, A., Villalobos, N., et al. (1996). Cysticercosis: identification and cloning of protective recombinant antigens. Journal of Parasitology,82, 250–254.
38. Toledo, A., Larralde, C., Fragoso, G., Gevorkian, G., Manoutcharian, K., Hernández, M., et al. (1999). Towards a Taenia solium cysticercosis vaccine: an epitope shared by Taenia crassiceps and Taenia solium protects mice against experimental cysticercosis. Infection and Immunity,67, 2522–2530.
39. Toledo, A., Fragoso, G., Rosas, G., Hernández, M., Gevorkian, G., López-Casillas, F., et al. (2001). Two epitopes shared by Taenia crassiceps and Taenia solium confer protection against murine T. crassiceps cysticercosis along with a prominent T1 response. Infection and Immunity,69, 1766–1773.
40. Sambrook, J., Fritsch, E. F., & Maniatis, T. (1989). Molecular cloning: A laboratory manual (2nd ed.). Plainview: Cold Spring Harbor Laboratory Press.
41. Horsch, R. B., Fry, J. E., Hoffmann, N. L., Eichholtz, D., Rogers, S. G., & Fraley, R. T. (1985). A simple and general method for transferring genes into plants. Science,227, 1229–1231.
42. Dellaporta, S. L., Wood, J., & Hicks, J. B. (1983). A plant DNA minipreparation: Version II. Plant Molecular Biology Reporter,1, 19–21.
43. Hernández, M., Beltrán, C., García, E., Fragoso, G., Gevorkian, G., Fleury, A., et al. (2000). Cysticercosis: towards the design of a diagnostic kit based on synthetic peptides. Immunology Letters,71, 13–17.
44. Liu, X., Constantinescu, S. N., Sun, Y., Bogan, J. S., Hirsch, D., Weinberg, R. A., & Lodish, H. F. (2000). Generation of mammalian cells stably expressing multiple genes at predetermined levels. Analytical Biochemistry,280, 20–28.
45. Fang, J., Qian, J. J., Yi, S., Harding, T. C., Tu, G. H., Van Roey, M., & Jooss, K. (2005). Stable antibody expression at therapeutic levels using the 2A peptide. Nature Biotechnology,23, 584–590.
46. Trichas, G., Begbie, J., & Srinivas, S. (2008). Use of the viral 2A peptide for bicistronic expression in transgenic mice. BMC Biology,6, 40–45.
47. Urwin, P., Yi, L., Martin, H., Atkinson, H., & Gilmartin, P. M. (2000). Functional characterization of the EMCV IRES in plants. The Plant Journal,24, 583–589.
48. Ngoi, S. M., Chien, A. C., & Lee, C. G. (2004). Exploiting internal ribosome entry sites in gene therapy vector design. Current Gene Therapy,4, 15–31.
49. De Felipe, P., Luke, G. A., Hughes, L. E., Gani, D., Halpin, C., & Ryan, M. D. (2006). E unum pluribus: multiple proteins from a self-processing polyprotein. Trends in Biotechnology,24, 68–75.
50. Ha, S. H., Liang, Y. S., Jung, H., Ahn, M. J., Suh, S. C., Kweon, S. J., et al. (2010). Application of two bicistronic systems involving 2A and IRES sequences to the biosynthesis of carotenoids in rice endosperm. Plant Biotechnology Journal,8, 928–938.
51. Rasala, B. A., Lee, P. A., Shen, Z., Briggs, S. P., Mendez, M., & Mayfield, S. P. (2012). Robust expression and secretion of Xylanase1 in Chlamydomonas reinhardtii by fusion to a selection gene and processing with the FMDV 2A peptide. PLoS One,7, 433–449.